Wellcome Trust’s Edwards Lifesciences EW Stock Holding History

Wellcome Trust’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$434M	Hold	4,800,000	–	–	4.82%	11
2026 Q1	$384M	Hold	4,800,000	–	–	4.75%	12
2025 Q4	$409M	Hold	4,800,000	–	–	4.39%	11
2025 Q3	$373M	Hold	4,800,000	–	–	4.06%	13
2025 Q2	$375M	Hold	4,800,000	–	–	4.33%	11
2025 Q1	$348M	Hold	4,800,000	–	–	4.35%	10
2024 Q4	$355M	Buy	4,800,000 +300,000	+7%	+$21M	4.29%	10
2024 Q3	$297M	Buy	4,500,000 +400,000	+10%	+$29.1M	3.62%	16
2024 Q2	$379M	Hold	4,100,000	–	–	4.84%	9
2024 Q1	$392M	Hold	4,100,000	–	–	4.71%	8
2023 Q4	$313M	Buy	4,100,000 +590,000	+17%	+$41.1M	3.87%	13
2023 Q3	$243M	Buy	3,510,000 +2,860,000	+440%	+$230M	3.23%	17
2023 Q2	$61.3M	Hold	650,000	–	–	0.81%	21
2023 Q1	$53.8M	Hold	650,000	–	–	0.75%	21
2022 Q4	$48.5M	Buy	650,000 +325,000	+100%	+$25M	0.72%	22
2022 Q3	$26.9M	Buy	+325,000	New	+$31.3M	0.42%	22

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust's EW Position: Q2 2026 in Review

Wellcome Trust held its Edwards Lifesciences (EW) position steady in Q2 2026 at 4,800,000 shares worth $434M. The position accounts for 4.82% of the portfolio, ranked #11.

Wellcome Trust first reported a position in EW in Q3 2022 and has held it in 16 quarters since. 1,330 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Wellcome Trust held 4,800,000 shares of Edwards Lifesciences worth $434M as of Q2 2026.
Wellcome Trust left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 4.82% of Wellcome Trust's portfolio in Q2 2026, its #11 holding.
Wellcome Trust first reported a position in Edwards Lifesciences in Q3 2022 and has held it in 16 quarters since.
1,330 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Wellcome Trust's 13F filing for Q2 2026, filed 9 Jul 2026.